Evaluating the Impact of the McMaster Optimal Aging Portal on Physical Mobility Outcomes

February 19, 2020 updated by: McMaster University

Evaluating the Impact of the McMaster Optimal Aging Portal on Knowledge, Behavioural Intentions and Health Behaviours Related to Physical Mobility

The McMaster Optimal Aging Portal (the Portal) was launched in 2014 to increase public access to trustworthy health information. The Portal helps readers to access evidence-based resources; identify trustworthy messages; and understand scientific findings. Now the investigators want to know whether using the Portal changes what people know and do to stay healthy and mobile.

This project will help us to:

  1. Understand how middle aged and older adults (age 40+) use the Portal to obtain information about maintaining and improving mobility
  2. Evaluate whether use of the Portal results in a change in knowledge about maintaining and improving mobility, or change in lifestyle behaviours that may help maintain or improve mobility with age.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Physically active lifestyles are important for health aging, but most Canadians do not meet published physical activity guidelines. This may be in part due to lack of access to evidence-based information on mobility and aging, and knowledge of strategies to maintain or improve mobility with age. The McMaster Optimal Aging Portal (the Portal) was launched in 2014 to increase public access to trustworthy health information. Now the investigators want to know if easy-to-understand evidence-based messages change what people know and do to stay healthy and mobile.

Sequential, explanatory mixed-methods design consisting of a two-armed randomized controlled trial and a qualitative process study to explore quantitative findings in depth.

Consent forms and a baseline survey will be sent to all interested participants. Following baseline data collection, participants will be stratified by previous Portal use, and randomized to the Knowledge Translation (KT) intervention or control group. During the 12-week KT intervention, intervention group participants will have access to the Portal and will receive mobility- focused weekly email alerts including blog posts and evidence summaries relevant to mobility and be invited to follow a Twitter and Facebook feed; a unique hashtag will be created to identify and collate relevant mobility information. Control group participants will be able to access the Portal in a 'self-serve' fashion, but will not receive targeted KT strategies.

Study Type

Interventional

Enrollment (Actual)

535

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Canada
    • Ontario
      • Hamilton, Ontario, Canada, L8P0A1
        • McMaster University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • English-speaking

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tailored Knowledge Translation
During the 12-week KT intervention, intervention group participants will have access to the Portal and will receive mobility-focused weekly email alerts including blog posts and evidence summaries relevant to mobility and be invited to follow a Twitter and Facebook feed; a unique hashtag will be created to identify and collate relevant mobility information.
Other: Tailored Knowledge Translation
Tailored knowledge translation strategies specific to maintaining and increasing physical mobility with age.
No Intervention: Control group
Participants in the control group will have access to the Portal in a 'self-serve' fashion. These participants will be able to browse the Portal, subscribe to email alerts, follow social media, etc. but will not receive the tailored mobility intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Website analytics
Time Frame: 12 weeks
Understanding participant engagement with the Portal and knowledge translation strategies
12 weeks
Email analytics
Time Frame: 12 weeks
Understanding participant engagement with the Portal and knowledge translation strategies
12 weeks
Google analytics
Time Frame: 12 weeks
Understanding participant engagement with the Portal and knowledge translation strategies
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge Questionnaire
Time Frame: 12 weeks, 3 months post-intervention
Participants knowledge of mobility recommendations and guidelines
12 weeks, 3 months post-intervention
Beliefs Questionnaire
Time Frame: 12 weeks, 3 months post-intervention
Participants beliefs about the importance of maintaining and improving mobility for health
12 weeks, 3 months post-intervention
Intentions Questionnaire
Time Frame: 12 weeks, 3 months post-intervention
Participants intentions to engage in lifestyle behaviours related to maintaining or improving mobility
12 weeks, 3 months post-intervention
Rapid Assessment of Physical Activity
Time Frame: 12 weeks, 3 months post-intervention
To quantify self-reported physical activity
12 weeks, 3 months post-intervention
Manty Preclinical Mobility Disability Scale
Time Frame: 12 weeks, 3 months post-intervention
Mobility limitation
12 weeks, 3 months post-intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Participant satisfaction
Time Frame: 12 weeks
Collected using qualitative interviews
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

McMaster University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 7, 2017

Primary Completion (Actual)

November 1, 2017

Study Completion (Actual)

December 31, 2018

Study Registration Dates

First Submitted

October 21, 2016

First Submitted That Met QC Criteria

October 26, 2016

First Posted (Estimate)

October 27, 2016

Study Record Updates

Last Update Posted (Actual)

February 21, 2020

Last Update Submitted That Met QC Criteria

February 19, 2020

Last Verified

March 1, 2019

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2017-04

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mobility Limitation

Clinical Trials on Tailored Knowledge Translation

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovakia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe